CB2 Insights Inc. (CSE:CBII,Forum) announced the appointment of a Medical Director in Colombia on Tuesday and intends to enter the market with a cannabis research focus.
For more on this, click here.
CB2 recently releasedits report on its fiscal Q2 2019 financial results, which sees a positive impact from new acquisitions.
FULL DISCLOSURE: CB2 Insights Inc. is a client of Stockhouse Publishing.